TerSera Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- TerSera Therapeutics's estimated annual revenue is currently $49M per year.
- TerSera Therapeutics's estimated revenue per employee is $201,000
Employee Data
- TerSera Therapeutics has 244 Employees.
- TerSera Therapeutics grew their employee count by 12% last year.
TerSera Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Quality Assurance | Reveal Email/Phone |
2 | SVP, General Manager Tersera Canada and U.S. Pain Business Unit | Reveal Email/Phone |
3 | VP Regulatory Affairs | Reveal Email/Phone |
4 | VP, Controller | Reveal Email/Phone |
5 | VP, Pharmacovigilance | Reveal Email/Phone |
6 | EVP Business Development | Reveal Email/Phone |
7 | SVP Finance | Reveal Email/Phone |
8 | VP & General Manager | Reveal Email/Phone |
9 | SVP Medical Affairs | Reveal Email/Phone |
10 | VP, Pricing and Reimbursement | Reveal Email/Phone |
TerSera Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $15.9M | 79 | 30% | N/A | N/A |
#2 | $91.5M | 455 | 7% | N/A | N/A |
#3 | $26.1M | 130 | 25% | $35M | N/A |
#4 | $15.3M | 76 | -4% | N/A | N/A |
#5 | $6.6M | 33 | -25% | N/A | N/A |
#6 | $5.6M | 28 | -7% | N/A | N/A |
#7 | $4.2M | 21 | -36% | N/A | N/A |
#8 | $10.1M | 50 | -25% | N/A | N/A |
#9 | $225.5M | 1122 | 19% | N/A | N/A |
#10 | $3.2M | 16 | -27% | N/A | N/A |
What Is TerSera Therapeutics?
TerSera Therapeutics acquires and develops specialty pharmaceutical products with a focus on select therapeutic areas. Our mission is to market products which truly make a difference for patients. Our focus is to bring intelligent solutions to prescribers and patients who need better solutions. We deliver a comprehensive set of programs that go beyond the therapy itself in order to provide improved outcomes for patients.
keywords:N/A
N/A
Total Funding
244
Number of Employees
$49M
Revenue (est)
12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
TerSera Therapeutics News
... Endo Pharmaceuticals Inc., AbbVie Inc., Contura Ltd., AstraZeneca plc, TerSera Therapeutics LLC, Shire, Informa plc, Merck KGaA.
Boehringer-Ingelheim, TerSera Therapeutics, Iroko Pharmaceuticals, Apotex, Yung Shin Pharmaceutical, Breckenridge Pharmaceutical,...
... Cox-2 Inhibitors Market Set to Witness Explosive Growth by 2029 | Boehringer-Ingelheim, TerSera Therapeutics, Iroko Pharmaceuticals.
Meloxicam Drug Market Latest Trend with Top key players: Boehringer-Ingelheim, TerSera Therapeutics, Iroko Pharmaceuticals, Apotex, Yung ...
Plenty of Opportunities in Meloxicam Drug Market Studied in Detail along with Top Companies as Boehringer-Ingelheim, TerSera Therapeutics, ...
Other Companies in Lake Forest
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $56.6M | 245 | -6% | N/A |
#2 | $49.9M | 252 | -4% | N/A |
#3 | $81M | 254 | -3% | N/A |
#4 | $38.7M | 257 | -17% | $40M |
#5 | $41.9M | 263 | N/A | N/A |